Advisory Board
Brian Conway,
Co-chair
|
Brian Conway, MD
bconway@interchange.ubc.ca
Assistant Professor
Department of Pharmacology & Therapeutics
University of British Columbia
Date of Birth
November 22, 1958
Education
McGill University, (MD, 1982)
McGill University, Queen Elizabeth Hospital (Mixed Internship, 1982-83)
McGill University, Royal Victoria Hospital (Internal Medicine Residency, 1983-86)
University of Manitoba (Infectious Diseases Fellowship, 1986-88)
Harvard University (MRC AIDS/Virology Fellowship, 1988-90)
Areas of Specialty
HIV clinical care, development of novel viral load assays, antiretroviral drug resistance testing
Recent Publications
Lamivudine-resistant human immunodeficiency
virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo.
Nijhuis M; Boucher CA; de Groot T; Keulen W, Danner S; Lange J; van Leeuwen R; de Jong D; Schuurman R. Journal of Infectious Diseases 1997; 176:398-405.
The duration of viral suppression is predicted by viral load during protease inhibitor therapy. Kempf D; Leonard J; Boucher C; Danner S; Sun E Molla A. 4th Conf Retro and Opportun Infect. 1997 Jan 22-26;:176 (abstract no. 603).
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir.
Molla A; Kempf DJ; Norbeck DW; Leonard JM; Boucher CA; et al. Nat Med. 1996 Jul;2(7):760-6.
|
